Virtu Financial’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Buy |
+187,395
| New | +$101K | 0.01% | 1040 |
|
|
2024
Q4 | – | Sell |
-172,665
| Closed | -$150K | – | 2003 |
|
|
2024
Q3 | $150K | Buy |
+172,665
| New | +$150K | 0.01% | 851 |
|
|
2023
Q3 | – | Sell |
-17,264
| Closed | -$22K | – | 1831 |
|
|
2023
Q2 | $22K | Buy |
+17,264
| New | +$22K | ﹤0.01% | 1246 |
|
|
2023
Q1 | – | Sell |
-24,880
| Closed | -$78K | – | 2041 |
|
|
2022
Q4 | $78K | Buy |
+24,880
| New | +$78K | 0.01% | 1010 |
|
|
2022
Q1 | – | Sell |
-15,176
| Closed | -$114K | – | 1977 |
|
|
2021
Q4 | $114K | Buy |
+15,176
| New | +$114K | 0.01% | 1075 |
|
|
2021
Q1 | – | Sell |
-13,543
| Closed | -$211K | – | 1983 |
|
|
2020
Q4 | $211K | Sell |
13,543
-7,689
| -36% | -$120K | 0.02% | 828 |
|
|
2020
Q3 | $201K | Sell |
21,232
-28,194
| -57% | -$267K | 0.03% | 593 |
|
|
2020
Q2 | $443K | Buy |
+49,426
| New | +$443K | 0.05% | 410 |
|
|
2019
Q4 | $105K | Sell |
12,548
-44,212
| -78% | -$370K | 0.01% | 1074 |
|
|
2019
Q3 | $514K | Buy |
+56,760
| New | +$514K | 0.04% | 504 |
|
|
2019
Q2 | – | Sell |
-25,430
| Closed | -$243K | – | 1794 |
|
|
2019
Q1 | $243K | Buy |
25,430
+14,215
| +127% | +$136K | 0.01% | 884 |
|
|
2018
Q4 | $129K | Buy |
+11,215
| New | +$129K | 0.01% | 1060 |
|
|
2018
Q3 | – | Sell |
-16,662
| Closed | -$237K | – | 2098 |
|
|
2018
Q2 | $237K | Sell |
16,662
-21,622
| -56% | -$308K | 0.01% | 1361 |
|
|
2018
Q1 | $727K | Buy |
+38,284
| New | +$727K | 0.04% | 509 |
|